TreeWAS – Variant ID: rs7638995

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I89.0 Lymphoedema, not elsewhere classified	0.011	0.989	0.000
Z04.8 Examination and observation for other specified reasons	0.000	0.989	0.011
Y95 Nosocomial condition	0.011	0.989	0.000
T51.0 Ethanol	0.000	0.990	0.010
I81 Portal vein thrombosis	0.010	0.990	0.000
S72.00 Fracture of neck of femur (closed)	0.000	0.991	0.009
I86.1 Scrotal varices	0.009	0.991	0.000
T39.1 4-Aminophenol derivatives	0.000	0.991	0.009
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.992	0.008
S72.40 Fracture of lower end of femur (closed)	0.000	0.992	0.008
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.992	0.008
I86 Varicose veins of other sites	0.008	0.992	0.000
I86.4 Gastric varices	0.007	0.993	0.000
S72.0 Fracture of neck of femur	0.000	0.993	0.007
S72.4 Fracture of lower end of femur	0.000	0.993	0.007
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.007	0.993	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.993	0.006
S72 Fracture of femur	0.000	0.994	0.006
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.994	0.006
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.994	0.006
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.994	0.006
T40.4 Other synthetic narcotics	0.000	0.994	0.006
T39.4 Antirheumatics, not elsewhere classified	0.000	0.994	0.006
T39.2 Pyrazolone derivatives	0.000	0.994	0.006
I86.8 Varicose veins of other specified sites	0.006	0.994	0.000
T51 Toxic effect of alcohol	0.000	0.994	0.006
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.994	0.006
T43.2 Other and unspecified antidepressants	0.000	0.994	0.006
I47.2 Ventricular tachycardia	0.000	0.994	0.006
I86.3 Vulval varices	0.006	0.994	0.000
I86.2 Pelvic varices	0.006	0.994	0.000
I86.0 Sublingual varices	0.006	0.994	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.994	0.006
S72.2 Subtrochanteric fracture	0.000	0.994	0.006
S72.01 Fracture of neck of femur (open)	0.000	0.994	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
T40.2 Other opioids	0.000	0.995	0.005
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.995	0.005
S72.20 Subtrochanteric fracture (closed)	0.000	0.995	0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.995	0.005
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.005	0.995	0.000
S72.9 Fracture of femur, part unspecified	0.000	0.995	0.005
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.005	0.995	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.995	0.005
S72.7 Multiple fractures of femur	0.000	0.995	0.005
T43.9 Psychotropic drug, unspecified	0.000	0.995	0.005
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.995	0.005
T43.6 Psychostimulants with abuse potential	0.000	0.995	0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.995	0.005
T46.1 Calcium-channel blockers	0.000	0.995	0.005
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.995	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.995	0.005
S72.8 Fractures of other parts of femur	0.000	0.995	0.005
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.995	0.005
T40.8 Lysergide [LSD]	0.000	0.995	0.005
T40.7 Cannabis (derivatives)	0.000	0.995	0.005
T40.5 Cocaine	0.000	0.995	0.005
T40.3 Methadone	0.000	0.995	0.005
T40.1 Heroin	0.000	0.995	0.005
T40.0 Opium	0.000	0.995	0.005
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.995	0.005
S72.3 Fracture of shaft of femur	0.000	0.995	0.005
S72.41 Fracture of lower end of femur (open)	0.000	0.995	0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.995	0.005
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.995	0.004
T40.6 Other and unspecified narcotics	0.000	0.995	0.004
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.005	0.995	0.000
T51.8 Other alcohols	0.000	0.996	0.004
T51.3 Fusel oil	0.000	0.996	0.004
T51.2 2-Propanol	0.000	0.996	0.004
T51.1 Methanol	0.000	0.996	0.004
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.996	0.004
T36 Poisoning by systemic antibiotics	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
I89.1 Lymphangitis	0.004	0.996	0.000
T42.4 Benzodiazepines	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
S72.21 Subtrochanteric fracture (open)	0.000	0.996	0.004
Z98.1 Arthrodesis status	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
S52.60 Fracture of lower end of both ulna and radius (closed)	0.000	0.996	0.004
T39.0 Salicylates	0.000	0.996	0.004
S72.90 Fracture of femur, part unspecified (closed)	0.000	0.996	0.004
U80.1 Methicillin resistant agent	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.004
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
T47.7 Emetics	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.000	0.996	0.004
T47.5 Digestants	0.000	0.996	0.004
T47.4 Other laxatives	0.000	0.996	0.004
T47.3 Saline and osmotic laxatives	0.000	0.996	0.004
T47.2 Stimulant laxatives	0.000	0.996	0.004
T47.0 Histamine H(2)-receptor antagonists	0.000	0.996	0.004
K83.0 Cholangitis	0.004	0.996	0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level	0.004	0.996	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.996	0.004
Y98 Lifestyle-related condition	0.004	0.996	0.000
Y97 Environmental-pollution-related condition	0.004	0.996	0.000
Y96 Work-related condition	0.004	0.996	0.000
S72.91 Fracture of femur, part unspecified (open)	0.000	0.996	0.004
S72.30 Fracture of shaft of femur (closed)	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.004
T63.4 Venom of other arthropods	0.000	0.996	0.004
D03.7 Melanoma in situ of lower limb, including hip	0.004	0.996	0.000
T51.9 Alcohol, unspecified	0.000	0.996	0.004
S72.71 Multiple fractures of femur (open)	0.000	0.996	0.003
S72.70 Multiple fractures of femur (closed)	0.000	0.996	0.003
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.000	0.996	0.004
T41.5 Therapeutic gases	0.000	0.996	0.003
T41.4 Anaesthetic, unspecified	0.000	0.996	0.003
T41.3 Local anaesthetics	0.000	0.996	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.003
T41.1 Intravenous anaesthetics	0.000	0.996	0.003
T41.0 Inhaled anaesthetics	0.000	0.996	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.003
T48.5 Anti-common-cold drugs	0.000	0.996	0.003
T48.4 Expectorants	0.000	0.996	0.003
T48.3 Antitussives	0.000	0.996	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.003
T48.0 Oxytocic drugs	0.000	0.996	0.003
T49.9 Topical agent, unspecified	0.000	0.996	0.003
T49.8 Other topical agents	0.000	0.996	0.003
T49.7 Dental drugs, topically applied	0.000	0.996	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.003
T49.2 Local astringents and local detergents	0.000	0.996	0.003
T49.1 Antipruritics	0.000	0.996	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.003
T63 Toxic effect of contact with venomous animals	0.000	0.996	0.004
S72.81 Fractures of other parts of femur (open)	0.000	0.996	0.003
D03.5 Melanoma in situ of trunk	0.004	0.996	0.000
T17.2 Foreign body in pharynx	0.004	0.996	0.000
S72.1 Pertrochanteric fracture	0.000	0.996	0.003
T18.1 Foreign body in oesophagus	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.996	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.996	0.003
T42.3 Barbiturates	0.000	0.996	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.996	0.003
S72.80 Fractures of other parts of femur (closed)	0.000	0.996	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.003
J03.9 Acute tonsillitis, unspecified	0.003	0.996	0.000
U80.0 Penicillin resistant agent	0.000	0.996	0.003
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
T36.6 Rifamycins	0.000	0.997	0.003
T36.5 Aminoglycosides	0.000	0.997	0.003
T36.4 Tetracyclines	0.000	0.997	0.003
T36.3 Macrolides	0.000	0.997	0.003
T36.2 Chloramphenicol group	0.000	0.997	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
Y91 Evidence of alcohol involvement determined by level of intoxication	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.997	0.003
U89.8 Agent resistant to other single specified antibiotic	0.000	0.997	0.003
Y90.8 Blood alcohol level of 240 mg/100 ml or more	0.003	0.997	0.000
I88 Nonspecific lymphadenitis	0.003	0.997	0.000
T36.0 Penicillins	0.000	0.997	0.003
S72.31 Fracture of shaft of femur (open)	0.000	0.997	0.003
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.003	0.997	0.000
W06.0 Home	0.003	0.997	0.000
Y90.9 Presence of alcohol in blood, level not specified	0.003	0.997	0.000
Y90.7 Blood alcohol level of 200-239 mg/100 ml	0.003	0.997	0.000
Y90.6 Blood alcohol level of 120-199 mg/100 ml	0.003	0.997	0.000
Y90.5 Blood alcohol level of 100-119 mg/100 ml	0.003	0.997	0.000
Y90.4 Blood alcohol level of 80-99 mg/100 ml	0.003	0.997	0.000
Y90.3 Blood alcohol level of 60-79 mg/100 ml	0.003	0.997	0.000
Y90.2 Blood alcohol level of 40-59 mg/100 ml	0.003	0.997	0.000
Y90.1 Blood alcohol level of 20-39 mg/100 ml	0.003	0.997	0.000
Y90.0 Blood alcohol level of less than 20 mg/100 ml	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
T18 Foreign body in alimentary tract	0.003	0.997	0.000
D03 Melanoma in situ	0.003	0.997	0.000
T58 Toxic effect of carbon monoxide	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
T59 Toxic effect of other gases, fumes and vapours	0.000	0.997	0.003
W07 Fall involving chair	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.997	0.003
U51 Admission status on psychiatric patients	0.000	0.997	0.003
W17 Other fall from one level to another	0.003	0.997	0.000
W07.9 Unspecified place	0.003	0.997	0.000
D03.4 Melanoma in situ of scalp and neck	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
T62 Toxic effect of other noxious substances eaten as food	0.000	0.997	0.003
T61 Toxic effect of noxious substances eaten as seafood	0.000	0.997	0.003
T60 Toxic effect of pesticides	0.000	0.997	0.003
T57 Toxic effect of other inorganic substances	0.000	0.997	0.003
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.000	0.997	0.003
T52 Toxic effect of organic solvents	0.000	0.997	0.003
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.000	0.997	0.003
T55 Toxic effect of soaps and detergents	0.000	0.997	0.003
T63.9 Toxic effect of contact with unspecified venomous animal	0.000	0.997	0.003
T63.8 Toxic effect of contact with other venomous animals	0.000	0.997	0.003
T63.6 Toxic effect of contact with other marine animals	0.000	0.997	0.003
T63.5 Toxic effect of contact with fish	0.000	0.997	0.003
T63.3 Venom of spider	0.000	0.997	0.003
T63.2 Venom of scorpion	0.000	0.997	0.003
T63.1 Venom of other reptiles	0.000	0.997	0.003
T63.0 Snake venom	0.000	0.997	0.003
W06 Fall involving bed	0.003	0.997	0.000
S72.11 Pertrochanteric fracture (open)	0.000	0.997	0.003
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.003	0.997	0.000
T17 Foreign body in respiratory tract	0.003	0.997	0.000
C16.9 Stomach, unspecified	0.003	0.997	0.000
W17.5 Trade and service area	0.003	0.997	0.000
T54 Toxic effect of corrosive substances	0.000	0.997	0.003
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.003	0.997	0.000
T65 Toxic effect of other and unspecified substances	0.000	0.997	0.003
D03.2 Melanoma in situ of ear and external auricular canal	0.003	0.997	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.997	0.003
T56 Toxic effect of metals	0.000	0.997	0.003
G93.3 Postviral fatigue syndrome	0.000	0.997	0.003
K07.6 Temporomandibular joint disorders	0.003	0.997	0.000
U81.0 Vancomycin resistant agent	0.000	0.997	0.003
Z99.1 Dependence on respirator	0.000	0.997	0.003
I47 Paroxysmal tachycardia	0.000	0.997	0.003
I85 Oesophageal varices	0.003	0.997	0.000
U89 Agent resistant to other and unspecified antibiotics	0.000	0.997	0.003
T18.0 Foreign body in mouth	0.003	0.997	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.003	0.997	0.000
J18.9 Pneumonia, unspecified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
W07.0 Home	0.003	0.997	0.000
U50 Level of care administered to neonates	0.000	0.997	0.003
U07 Emergency use of U07	0.000	0.997	0.003
U06 Emergency use of U06	0.000	0.997	0.003
U04 Severe acute respiratory syndrome [SARS]	0.000	0.997	0.003
U52 First in a series of a regular day/night admissions	0.000	0.997	0.003
I87.2 Venous insufficiency (chronic) (peripheral)	0.000	0.997	0.002
W07.5 Trade and service area	0.003	0.997	0.000
W17.6 Industrial and construction area	0.003	0.997	0.000
W17.4 Street and highway	0.003	0.997	0.000
W00-W19 Falls	0.003	0.997	0.000
T18.9 Foreign body in alimentary tract, part unspecified	0.003	0.997	0.000
T59.8 Other specified gases, fumes and vapours	0.000	0.997	0.003
W01.7 Farm	0.003	0.997	0.000
Y91.3 Very severe alcohol intoxication	0.002	0.997	0.000
Y91.2 Severe alcohol intoxication	0.002	0.997	0.000
Y91.1 Moderate alcohol intoxication	0.002	0.997	0.000
Y91.0 Mild alcohol intoxication	0.002	0.997	0.000
C22.0 Liver cell carcinoma	0.003	0.997	0.000
I47.1 Supraventricular tachycardia	0.000	0.997	0.003
I88.8 Other nonspecific lymphadenitis	0.002	0.997	0.000
I88.1 Chronic lymphadenitis, except mesenteric	0.002	0.997	0.000
I88.0 Nonspecific mesenteric lymphadenitis	0.002	0.997	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.003	0.997	0.000
I74.8 Embolism and thrombosis of other arteries	0.003	0.997	0.000
D03.9 Melanoma in situ, unspecified	0.002	0.997	0.000
D03.8 Melanoma in situ of other sites	0.002	0.997	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.002	0.997	0.000
D03.0 Melanoma in situ of lip	0.002	0.997	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.000	0.997	0.002
K07.2 Anomalies of dental arch relationship	0.002	0.997	0.000
T18.8 Foreign body in other and multiple parts of alimentary tract	0.002	0.997	0.000
T18.4 Foreign body in colon	0.002	0.997	0.000
T18.3 Foreign body in small intestine	0.002	0.997	0.000
T18.2 Foreign body in stomach	0.002	0.997	0.000
I74 Arterial embolism and thrombosis	0.003	0.997	0.000
T17.5 Foreign body in bronchus	0.002	0.997	0.000
W01.6 Industrial and construction area	0.002	0.997	0.000
T16 Foreign body in ear	0.002	0.998	0.000
C24.0 Extrahepatic bile duct	0.002	0.998	0.000
C22.1 Intrahepatic bile duct carcinoma	0.002	0.998	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.002	0.998	0.000
T59.7 Carbon dioxide	0.000	0.998	0.002
T59.6 Hydrogen sulphide	0.000	0.998	0.002
T59.5 Fluorine gas and hydrogen fluoride	0.000	0.998	0.002
T59.4 Chlorine gas	0.000	0.998	0.002
T59.3 Lachrymogenic gas	0.000	0.998	0.002
T59.2 Formaldehyde	0.000	0.998	0.002
T59.1 Sulphur dioxide	0.000	0.998	0.002
T59.0 Nitrogen oxides	0.000	0.998	0.002
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.002
W07.2 School, other institution and public administrative area	0.002	0.998	0.000
W07.8 Other specified place	0.002	0.998	0.000
W07.7 Farm	0.002	0.998	0.000
W07.6 Industrial and construction area	0.002	0.998	0.000
W07.4 Street and highway	0.002	0.998	0.000
W07.3 Sports and athletics area	0.002	0.998	0.000
W07.1 Residential institution	0.002	0.998	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
K07.9 Dentofacial anomaly, unspecified	0.002	0.998	0.000
W17.9 Unspecified place	0.002	0.998	0.000
W17.8 Other specified place	0.002	0.998	0.000
W17.0 Home	0.002	0.998	0.000
W17.7 Farm	0.002	0.998	0.000
W17.3 Sports and athletics area	0.002	0.998	0.000
W17.2 School, other institution and public administrative area	0.002	0.998	0.000
W17.1 Residential institution	0.002	0.998	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.998	0.002
G47.9 Sleep disorder, unspecified	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T52.9 Organic solvent, unspecified	0.000	0.998	0.002
T52.8 Other organic solvents	0.000	0.998	0.002
T52.4 Ketones	0.000	0.998	0.002
T52.3 Glycols	0.000	0.998	0.002
T52.2 Homologues of benzene	0.000	0.998	0.002
T52.1 Benzene	0.000	0.998	0.002
T52.0 Petroleum products	0.000	0.998	0.002
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.000	0.998	0.002
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.000	0.998	0.002
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.000	0.998	0.002
T53.5 Chlorofluorocarbons	0.000	0.998	0.002
T53.4 Dichloromethane	0.000	0.998	0.002
T53.3 Tetrachloroethylene	0.000	0.998	0.002
T53.2 Trichloroethylene	0.000	0.998	0.002
T53.1 Chloroform	0.000	0.998	0.002
T53.0 Carbon tetrachloride	0.000	0.998	0.002
T57.9 Inorganic substance, unspecified	0.000	0.998	0.002
T57.8 Other specified inorganic substances	0.000	0.998	0.002
T57.3 Hydrogen cyanide	0.000	0.998	0.002
T57.2 Manganese and its compounds	0.000	0.998	0.002
T57.1 Phosphorus and its compounds	0.000	0.998	0.002
T57.0 Arsenic and its compounds	0.000	0.998	0.002
T60.9 Pesticide, unspecified	0.000	0.998	0.002
T60.8 Other pesticides	0.000	0.998	0.002
T60.4 Rodenticides	0.000	0.998	0.002
T60.3 Herbicides and fungicides	0.000	0.998	0.002
T60.2 Other insecticides	0.000	0.998	0.002
T60.1 Halogenated insecticides	0.000	0.998	0.002
T60.0 Organophosphate and carbamate insecticides	0.000	0.998	0.002
T61.9 Toxic effect of unspecified seafood	0.000	0.998	0.002
T61.8 Toxic effect of other seafoods	0.000	0.998	0.002
T61.2 Other fish and shellfish poisoning	0.000	0.998	0.002
T61.1 Scombroid fish poisoning	0.000	0.998	0.002
T61.0 Ciguatera fish poisoning	0.000	0.998	0.002
T62.9 Noxious substance eaten as food, unspecified	0.000	0.998	0.002
T62.8 Other specified noxious substances eaten as food	0.000	0.998	0.002
T62.2 Other ingested (parts of) plant(s)	0.000	0.998	0.002
T62.1 Ingested berries	0.000	0.998	0.002
T62.0 Ingested mushrooms	0.000	0.998	0.002
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.002	0.998	0.000
K07 Dentofacial anomalies [including malocclusion]	0.002	0.998	0.000
W05 Fall involving wheelchair	0.002	0.998	0.000
W00 Fall on same level involving ice and snow	0.002	0.998	0.000
H57.1 Ocular pain	0.002	0.998	0.000
N42.8 Other specified disorders of prostate	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
W06.2 School, other institution and public administrative area	0.002	0.998	0.000
W06.9 Unspecified place	0.002	0.998	0.000
W06.8 Other specified place	0.002	0.998	0.000
W06.7 Farm	0.002	0.998	0.000
W06.6 Industrial and construction area	0.002	0.998	0.000
W06.5 Trade and service area	0.002	0.998	0.000
W06.4 Street and highway	0.002	0.998	0.000
W06.3 Sports and athletics area	0.002	0.998	0.000
W06.1 Residential institution	0.002	0.998	0.000
C16 Malignant neoplasm of stomach	0.002	0.998	0.000
I82 Other venous embolism and thrombosis	0.002	0.998	0.000
C24.1 Ampulla of Vater	0.002	0.998	0.000
T17.8 Foreign body in other and multiple parts of respiratory tract	0.002	0.998	0.000
T17.4 Foreign body in trachea	0.002	0.998	0.000
T17.3 Foreign body in larynx	0.002	0.998	0.000
T17.1 Foreign body in nostril	0.002	0.998	0.000
T17.0 Foreign body in nasal sinus	0.002	0.998	0.000
T18.5 Foreign body in anus and rectum	0.002	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.002	0.998	0.000
T54.3 Corrosive alkalis and alklali-like substances	0.000	0.998	0.002
T54.2 Corrosive acids and acid-like substances	0.000	0.998	0.002
T54.1 Other corrosive organic compounds	0.000	0.998	0.002
T54.0 Phenol and phenol homologues	0.000	0.998	0.002
I88.9 Nonspecific lymphadenitis, unspecified	0.002	0.998	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.998	0.002
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.002	0.998	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.000	0.998	0.002
T56.9 Metal, unspecified	0.000	0.998	0.002
T56.7 Beryllium and its compounds	0.000	0.998	0.002
T56.6 Tin and its compounds	0.000	0.998	0.002
T56.5 Zinc and its compounds	0.000	0.998	0.002
T56.4 Copper and its compounds	0.000	0.998	0.002
T56.3 Cadmium and its compounds	0.000	0.998	0.002
T56.2 Chromium and its compounds	0.000	0.998	0.002
T56.1 Mercury and its compounds	0.000	0.998	0.002
T56.0 Lead and its compounds	0.000	0.998	0.002
T65.8 Toxic effect of other specified substances	0.000	0.998	0.002
T65.6 Paints and dyes, not elsewhere classified	0.000	0.998	0.002
T65.5 Nitroglycerin and other nitric acids and esters	0.000	0.998	0.002
T65.4 Carbon disulphide	0.000	0.998	0.002
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.000	0.998	0.002
T65.2 Tobacco and nicotine	0.000	0.998	0.002
T65.1 Strychnine and its salts	0.000	0.998	0.002
T65.0 Cyanides	0.000	0.998	0.002
H57.8 Other specified disorders of eye and adnexa	0.002	0.998	0.000
T59.9 Gases, fumes and vapours, unspecified	0.000	0.998	0.002
U89.9 Agent resistant to unspecified antibiotic	0.000	0.998	0.002
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.002	0.998	0.000
R10.0 Acute abdomen	0.002	0.998	0.000
I74.5 Embolism and thrombosis of iliac artery	0.002	0.998	0.000
O72.1 Other immediate postpartum haemorrhage	0.000	0.998	0.002
W01.9 Unspecified place	0.002	0.998	0.000
W01.8 Other specified place	0.002	0.998	0.000
W01.5 Trade and service area	0.002	0.998	0.000
W01.4 Street and highway	0.002	0.998	0.000
W01.3 Sports and athletics area	0.002	0.998	0.000
W01.2 School, other institution and public administrative area	0.002	0.998	0.000
W01.0 Home	0.002	0.998	0.000
T54.9 Corrosive substance, unspecified	0.000	0.998	0.002
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.002	0.998	0.000
I80 Phlebitis and thrombophlebitis	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
Chapter XXII Codes for special purposes	0.000	0.998	0.002
C16.6 Greater curvature of stomach, unspecified	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.002
U06.9 Emergency use of U06.9	0.000	0.998	0.002
U06.8 Emergency use of U06.8	0.000	0.998	0.002
U06.7 Emergency use of U06.7	0.000	0.998	0.002
U06.6 Emergency use of U06.6	0.000	0.998	0.002
U06.5 Emergency use of U06.5	0.000	0.998	0.002
U06.4 Emergency use of U06.4	0.000	0.998	0.002
U06.3 Emergency use of U06.3	0.000	0.998	0.002
U06.2 Emergency use of U06.2	0.000	0.998	0.002
U06.1 Emergency use of U06.1	0.000	0.998	0.002
U06.0 Emergency use of U06.0	0.000	0.998	0.002
U07.9 Emergency use of U07.9	0.000	0.998	0.002
U07.8 Emergency use of U07.8	0.000	0.998	0.002
U07.7 Emergency use of U07.7	0.000	0.998	0.002
U07.6 Emergency use of U07.6	0.000	0.998	0.002
U07.5 Emergency use of U07.5	0.000	0.998	0.002
U07.4 Emergency use of U07.4	0.000	0.998	0.002
U07.3 Emergency use of U07.3	0.000	0.998	0.002
U07.2 Emergency use of U07.2	0.000	0.998	0.002
U07.1 Emergency use of U07.1	0.000	0.998	0.002
U07.0 Emergency use of U07.0	0.000	0.998	0.002
U50.9 Inquest Adjourned Death	0.000	0.998	0.002
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.002
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.002
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.002
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.002
I87 Other disorders of veins	0.001	0.998	0.001
K07.4 Malocclusion, unspecified	0.002	0.998	0.000
W01.1 Residential institution	0.002	0.998	0.000
W16 Diving or jumping into water causing injury other than drowning or submersion	0.002	0.998	0.000
W12 Fall on and from scaffolding	0.002	0.998	0.000
W09 Fall involving playground equipment	0.002	0.998	0.000
W04 Fall while being carried or supported by other persons	0.002	0.998	0.000
C24.9 Biliary tract, unspecified	0.002	0.998	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.002	0.998	0.000
V20-V29 Motorcycle rider injured in transport accident	0.002	0.998	0.000
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.002	0.998	0.000
T65.9 Toxic effect of unspecified substance	0.000	0.998	0.002
W00.3 Sports and athletics area	0.002	0.998	0.000
W11 Fall on and from ladder	0.002	0.998	0.000
C16.5 Lesser curvature of stomach, unspecified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations